ReviewFrontiers in pharmacology2026

Oral small-molecule GLP-1 receptor agonists: a new Frontier in cardiometabolic medicine.

Jinkai Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.